Summary
AmerisourceBergen Corporation (now Cencora, Inc.), in a filing dated September 27, 2011, announced a significant strategic acquisition. The company has entered into a definitive agreement to purchase TheraCom, LLC from CVS Caremark Corporation for approximately $250 million, subject to closing working capital adjustments. TheraCom specializes in providing comprehensive support services to pharmaceutical and biotechnology drug manufacturers, including critical consulting and reimbursement assistance.
Key Highlights
- 1AmerisourceBergen agrees to acquire TheraCom, LLC for $250 million.
- 2TheraCom is a subsidiary of CVS Caremark Corporation.
- 3The acquisition is expected to close in the first quarter of fiscal year 2012 (ending December 31, 2011).
- 4TheraCom offers consulting and reimbursement services to drug manufacturers.
- 5TheraCom will be integrated into AmerisourceBergen Consulting Services, specifically joining The Lash Group.
- 6The transaction is subject to customary working capital adjustments.
Frequently Asked Questions
The main purpose of this 8-K filing is to announce AmerisourceBergen Corporation's definitive agreement to acquire TheraCom, LLC.
TheraCom, LLC provides a range of support services to pharmaceutical and biotechnology drug manufacturers, including consulting and reimbursement services.
The filing states the purchase price is approximately $250 million, subject to working capital adjustments. While specific financial impact details are not provided in this short 8-K, the acquisition suggests a strategic move to expand AmerisourceBergen's consulting and support services for drug manufacturers.
The acquisition is anticipated to close during the first quarter of AmerisourceBergen's fiscal year 2012, which concludes on December 31, 2011.